See on automaatne vaade, mis põhineb projekti Vikiandmed andmetel.
Artiklit veel pole, kuid saad aidata seda luua.
medication which is used as an anticoagulant (blood thinner)
Välised allikad
CAS Registry Number | |
MeSH descriptor ID | D006493teema nimetus kujul: Heparin |
Encyclopædia Britannica Online ID | science/heparinteema nimetus kujul: heparin |
ChEMBL ID | |
Gran Enciclopèdia Catalana ID | |
Human Metabolome Database ID | |
Römpp online ID | |
WordNet 3.1 Synset ID | |
JSTOR topic ID | |
AICS Chemical ID (BEING DELETED) | |
PatientsLikeMe treatment ID | |
ECHA Substance Infocard ID | |
NALT ID | |
National Library of Israel J9U ID | |
Freebase | |
Microsoft Academic ID | |
LCCN | sh85060283[9]teema nimetus kujul: Heparin |
PubChem CID | |
UniChem compound ID | |
Quora topic ID | |
KEGG ID | |
OpenAlex ID | |
DrugBank ID | |
Elhuyar ZTH ID | |
WikiProjectMed ID | |
CosIng number | |
UNII | |
MedlinePlus drug identifier | |
ChEBI ID | |
IEDB Epitope ID | |
Foundational Model of Anatomy ID | 82839[16]teema nimetus kujul: Heparin |
ATC code | |
Den Store Danske ID | |
EC number | |
Läti Rahvusraamatukogu ID | |
NDL-tunnus | |
Gran Enciclopèdia Catalana ID (former scheme) | |
WikiSkripta article ID | |
BNF | 11965281p[9]teema nimetus kujul: Héparines |
Great Russian Encyclopedia Online ID (old version) | |
ChemSpider ID | |
BNCF Thesaurus ID | |
Guide to Pharmacology Ligand ID | |
NL CR AUT ID | ph1144691[19]teema nimetus kujul: heparin |
World Health Organisation international non-proprietary name numeric ID | |
Brockhaus Enzyklopädie online ID | |
MeSH tree code | |
RxNorm ID | |
DSSTox substance ID | |
üksikjuht nähtusest
essential medicine
group or class of chemical substances
osa objektist
response to heparin[21]subjektil on roll: reactant
cellular response to heparin[21]subjektil on roll: reactant
keemiline struktuur
mass/kaal
1039,9 aatommassiühik[22] World Health Organisation international non-proprietary name
medical condition treated
significant drug interaction
enoxaparin[25]side effect: retroperitoneal hemorrhage
dalteparin[25]side effect: retroperitoneal hemorrhage
Varfariin[26]side effect: retroperitoneal hemorrhage
urokinase[25]side effect: retroperitoneal hemorrhage
alteplase[25]side effect: retroperitoneal hemorrhage
tenecteplase[25]side effect: retroperitoneal hemorrhage
Streptokinase[25]side effect: retroperitoneal hemorrhage
rivaroxaban[25]side effect: retroperitoneal hemorrhage
apixaban[26]side effect: retroperitoneal hemorrhage
Aspiriin[25]side effect: retroperitoneal hemorrhage
nabumetone[25]side effect: retroperitoneal hemorrhage
Naprokseen[25]side effect: retroperitoneal hemorrhage
celecoxib[25]side effect: retroperitoneal hemorrhage
Diclofenac[25]side effect: retroperitoneal hemorrhage
piroxicam[25]side effect: retroperitoneal hemorrhage
meloksikaam[25]side effect: retroperitoneal hemorrhage
(RS)-fenoprofen[25]side effect: retroperitoneal hemorrhage
(+-)-flurbiprofen[25]side effect: retroperitoneal hemorrhage
ibuprofeen[25]side effect: retroperitoneal hemorrhage
Indometatsiin[25]side effect: retroperitoneal hemorrhage
(RS)-ketoprofen[25]side effect: retroperitoneal hemorrhage
(RS)-etodolac[25]side effect: retroperitoneal hemorrhage
sulindac[25]side effect: retroperitoneal hemorrhage
clopidogrel[25]side effect: retroperitoneal hemorrhage
eptifibatide[25]side effect: retroperitoneal hemorrhage
iloprost[25]side effect: retroperitoneal hemorrhage
prostacyclin[25]side effect: retroperitoneal hemorrhage
parecoxib[25]side effect: retroperitoneal hemorrhage
tirofiban[25]side effect: retroperitoneal hemorrhage
aceclofenac[25]side effect: retroperitoneal hemorrhage
tenoxicam[25]side effect: retroperitoneal hemorrhage
prasugrel[25]side effect: retroperitoneal hemorrhage
ticagrelor[25]side effect: retroperitoneal hemorrhage
cangrelor[25]side effect: retroperitoneal hemorrhage
abciximab[25]side effect: retroperitoneal hemorrhage
perindopril[25]side effect: Hüperkaleemia
nabumetone[25]side effect: Hüperkaleemia
celecoxib[25]side effect: Hüperkaleemia
Diclofenac[25]side effect: Hüperkaleemia
piroxicam[25]side effect: Hüperkaleemia
meloksikaam[25]side effect: Hüperkaleemia
(RS)-fenoprofen[25]side effect: Hüperkaleemia
(+-)-flurbiprofen[25]side effect: Hüperkaleemia
(RS)-ketoprofen[25]side effect: Hüperkaleemia
(RS)-etodolac[25]side effect: Hüperkaleemia
sulindac[25]side effect: Hüperkaleemia
enoxaparin[25]side effect: Hüperkaleemia
dalteparin[25]side effect: Hüperkaleemia
parecoxib[25]side effect: Hüperkaleemia
aceclofenac[25]side effect: Hüperkaleemia
tenoxicam[25]side effect: Hüperkaleemia
route of administration
subcutaneous injection
intravenous injection
pregnancy category
Australian pregnancy category C
kirjeldatud allikas
Armenian Soviet Encyclopedia, vol. 6 Commonsi kategooria
Heparins
teema peakategooria
Category:Heparins
Viited
- ↑ 1,0 1,1 1,2 1,3 1,4 1,5 DrugBank
- ↑ SciFinder
- ↑ DrugBank, inglise keel, 17. november 2015, 06779, Dalteparin
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 8. veebruar 2021
- ↑ GF WordNet
- ↑ http://echa.europa.eu/de/information-on-chemicals/registered-substances
- ↑ National Library of Israel
- ↑ Freebase Data Dumps, 28. oktoober 2013
- ↑ 9,0 9,1 Nuovo soggettario, https://thes.bncf.firenze.sbn.it/termine.php?id=2979, 13. juuni 2021
- ↑ UniChem
- ↑ Quora
- ↑ 12,0 12,1 OpenAlex, 26. jaanuar 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
- ↑ CosIng database, 28. detsember 2019, 34248, HEPARIN, CAS no.: 9005-49-6
- ↑ ChEBI release 2019-10-02
- ↑ Immune Epitope Database and Analysis Resource, 1. märts 2022, 131188
- ↑ Foundational Model of Anatomy, 1. august 2019
- ↑ ECHA Substance Infocard database, 27. detsember 2018, 100.029.698, Heparin, CAS no.: 9005-49-6
- ↑ Firenze Keskrahvusraamatukogu
- ↑ ph1144691, 22. märts 2022, Czech National Authority Database
- ↑ https://mednet-communities.net/inn/db/ViewINN.aspx?i=392
- ↑ 21,0 21,1 Gene Ontology release 2019-11-16
- ↑ 22,0 22,1 PubChem, 23. september 2021, 22833565
- ↑ Recommended INN: List 26, 1986
- ↑ Inxight: Drugs Database, 2. november 2018, https://drugs.ncats.io/drug/T2410KM04A, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017037s178lbl.pdf
- ↑ 25,00 25,01 25,02 25,03 25,04 25,05 25,06 25,07 25,08 25,09 25,10 25,11 25,12 25,13 25,14 25,15 25,16 25,17 25,18 25,19 25,20 25,21 25,22 25,23 25,24 25,25 25,26 25,27 25,28 25,29 25,30 25,31 25,32 25,33 25,34 25,35 25,36 25,37 25,38 25,39 25,40 25,41 25,42 25,43 25,44 25,45 25,46 25,47 25,48 25,49 25,50 25,51 A reference set of clinically relevant adverse drug-drug interactions, hypothetically
- ↑ 26,0 26,1 A reference set of clinically relevant adverse drug-drug interactions, probably